Laboratory for Cancer Biology, Metabolism & Immunotherapy

PUBLICATIONS UPDATE 

Shashi Gujar*,†, Jonathan G. Pol*, Vishnu Vijay Vijayan, Preethi Gopalakrishnan Nair, Unnikrishnan Babukuttan Sheela, Anurag Banerjee, Guido Kroemer†. “Repurposing COVID-19 (and other) mRNA vaccines to boost cancer immunotherapy efficacy: Mechanistic insights and future directions”. Journal for ImmunoTherapy of Cancer (2026) Accepted

Ehab M Ezzaldeen#, Vishnu Vijay Vijayan#, Preethi Gopalakrishnan Nair, Unnikrishnan Babukuttan Sheela, Anurag Banerjee, Shashi Gujar. “Dendritic cells as central coordinators of oncolytic virus-induced antitumor immunity”. Seminars in Immunology (2026) Accepted

Preethi Gopalakrishnan Nair#, Unnikrishnan Babukuttan Sheela#, Vishnu Vijay Vijayan, Susan E. Howlett*, Pieter Cullis*, Shashi Gujar*. “Targeting Age-Associated Immune Senescence via Nanoparticle-Based Metabolic Reprogramming”, ACS Nano (2026).

Giacomantonio, Michael A., Vishnu Vijay Vijayan, Preethi G. Nair, Gopal P. Pathak, Barry E. Kennedy, Joao A. Paulo, Teresa McMillen et al. "Subversion of kynurenine-induced AHR activation in CD8 T cells by kynureninase-expressing antigen-presenting cells." Cell Reports 45, no. 4 (2026).

Vijayan, Vishnu Vijay, Preethi Gopalakrishnan Nair, and Shashi Gujar. "Multiprong CD38 targeting to enhance anti-PD1 immune checkpoint blockade efficacy." Oncoimmunology 13, no. 1 (2024): 2400429.

Our perspective on OV cancer immunotherapy is highlighted within following publications:

• GUJAR S*, Pol J*, Kumar V, Lizarralde-Guerrero M, Konda P, Kroemer G, Bell J. Tutorial: Design, Production and Testing of Oncolytic Viruses for Cancer Immunotherapy. Nature Protocols. 2024. Accepted.

• GUJAR S, Bell J and Diallo JS. Cancer immunotherapy with oncolytic viruses. Cell. 2019. [PMID: 30794777].

• GUJAR S*, Pol J*, Kim Y, Lee P and Kroemer G. 2018. Antitumor benefits of antiviral immunity: an underappreciated aspect of oncolytic virotherapies. Trends in Immunology. 2018 (Cell Press). S1471-4906(17)30228-4. [Selected as the cover feature of March 2018 issue of the journal, and also highlighted on Cell.com]. [PMID: 29275092].

• Lee P and GUJAR S. 2018. Potentiating prostate cancer immunotherapy with oncolytic viruses. Nature Reviews Urology. 2018. [Featured on the cover page of April 2018 issue of the journal]. [PMID: 29434366].

Full list of our publications can be found here:

https://www.ncbi.nlm.nih.gov/myncbi/1J9D7vxzpMy5T/bibliography/public/

For more publications: Pubmed